Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 in Acne Vulgaris
NCT02656485Phase 2Completed
- Sponsor
- AOBiome
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of B244 in acne vulgaris, sponsored by AOBiome. Started Aug 2015; status: completed.
02
Drugs
B244
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02656485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656485.